Journal for ImmunoTherapy of Cancer (Nov 2020)

370 Pharmacodynamic assessment of a novel FAP-targeted 4–1BB agonist, administered as single agent and in combination with atezolizumab to patients with advanced solid tumors

  • Josep Tabernero,
  • Maurizio Ceppi,
  • Victor Moreno,
  • Michael Hettich,
  • Miguel Sanmamed,
  • Christina Claus,
  • Tatiana Hernandez,
  • Iben Spanggaard,
  • Analia Azaro,
  • Maria Martinez Garcia,
  • Alejo Rodriguez-Vida,
  • Florian Heil,
  • Oliver Krieter,
  • Oliver Grimm,
  • Marta Canamero,
  • Jose Duarte,
  • Alexandra-Cristina Nica,
  • Iakov Davydov,
  • Chia-Huey Ooi,
  • Christian Heichinger,
  • Ernesto Guarin,
  • Radoiane Helbaj,
  • Tamara Tanos,
  • Eveline Nueesch,
  • Irene Moreno

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0370
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.